Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Revenue (2016 - 2025)

Historic Revenue for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $4.8 million.

  • Nephros' Revenue rose 3541.79% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year increase of 3236.38%. This contributed to the annual value of $14.2 million for FY2024, which is 53.38% down from last year.
  • Nephros' Revenue amounted to $4.8 million in Q3 2025, which was up 3541.79% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, Nephros' Revenue peaked at $4.9 million during Q1 2025, and registered a low of $2.2 million during Q1 2022.
  • For the 5-year period, Nephros' Revenue averaged around $3.3 million, with its median value being $3.3 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first crashed by 2108.92% in 2022, then soared by 7123.67% in 2023.
  • Quarter analysis of 5 years shows Nephros' Revenue stood at $2.7 million in 2021, then dropped by 5.71% to $2.6 million in 2022, then increased by 27.21% to $3.3 million in 2023, then rose by 18.93% to $3.9 million in 2024, then grew by 23.1% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $4.4 million for Q2 2025, and $4.9 million during Q1 2025.